Merck
CN
Search Within
Document Type

2043-61-0

Applied Filters:
Keyword:'2043-61-0'
Showing 1-5 of 5 results for "2043-61-0" within Technical Documents
Data Sheet 1.10886.0500 Blood Agar Base
basket 1.07040.0001 1ea Merck KGaA, 64271 Darmstadt, Germany Fax: +49 (0) 61 51 / 72-60 80 mibio@merckgroup.com www.merckmillipore.com/biomonitoring
Celltransmissions Newsletter
324 (1997). 60. Bolger, G.E., et al., Biochem. J., 328, 539-48 (1997). 61. Ruppert, D. and Weithmann, K.U., Life Sci., 31, 2037-2043 (1982). 62. Haynes, J. Jr., et al., Am. J. Physiol., 261, H487-492 (1991
Calbiochem Biologics 29.4
Page 10 Tech Service Freecall 0800-100-3496 10 NEW! Protein Kinase Inhibitors AGL 2043 A cell-permeable, potent, selective, ATP-competitive, and reversible inhibitor of type III receptor
Inhibitor Sourcebook 3rd Edition
solution of AG490 (Cat. No. 658401) in DMSO. 5 mg AGL 2043 121790 {1,2-Dimethyl-6-(2-thienyl)-imidazolo[5,4-g]quinoxaline; Tyrphostin AGL 2043} A cell-permeable tricyclic quinoxaline compound that acts
Katalog neoLab
with AutoCal 0-2000 µS / 0-20 mS 8-1306 ECTestr 11+ with AutoCal 0-2000 µS / 0-20 mS / 2 bis 200 µS 8-1307 TDSTestr 11+ 0-200 ppm / 0-2000 ppm / 0-10 ppt 8-1308